Dr. Pallab Bhattacharya, Ph.D.
Professor , Department of Pharmacology and Toxicology
-
National Institute of Pharmaceutical Education and Research (NIPER),Ahmedabad -
pallab[dot]bhattacharya[at]niperahm[dot]ac[dot]in, pallab[dot]bhattacharya[at]niperahm[dot]res[dot]in -
079-65181200 -
Gandhinagar -
Gujarat
Research Interest
- Cerebrovascular Disease
- Stroke and Co-morbidity
- Endovascular Cell Therapy
- Immunotherapy
- Biomarker
- Drug Repurposing
- Targeted Brain Drug Delivery
- Neurotherapeutics
Experience
- 2024 - till date
Professor
NIPER- Ahmedabad, Palaj, Gandhinagar
- 2019 - 2024
Associate Professor
NIPER- Ahmedabad, Palaj, Gandhinagar
- Jun 2019-July 2019
Visiting Scientist
Department of Molecular Biology and Genetics, DAGMAR Danish Center for Transgenic Mice, Aarhus, Denmark
- July 2016 - Dec 2019
Assistant Professor
NIPER- Ahmedabad, Palaj, Gandhinagar
- Jun 2017-Aug 2017
Visiting Scientist
Department of Neurosurgery, Boston Children’s Hospital, Harvard Medical School, Boston USA
- February 2016 - June 2016
Senior Scientist
Stem Cell Biology Laboratory, Department of Biochemistry, Pt. Jawahar Lal Nehru Memorial Medical College, Raipur, India
- June 2012 - January 2016
Post-Doctoral Fellow
Department of Neurology, Miller School of Medicine, University of Miami, Miami, Florida, USA
- January 2009 – May 2012
Senior Research Fellow
School of Biomedical Engineering, Indian Institute of Technology(BHU), Varanasi, India
- January 2007 – December 2009
Junior Research Fellow
School of Biomedical Engineering, Indian Institute of Technology(BHU), Varanasi, India
- August 2006 – January 2007
Research Fellow, School of Biomedical Engineering
Indian Institute of Technology(BHU), Varanasi, India
Research Grants
Extramural Research Grant
- Title: Investigating the therapeutic synergism of stem cell therapy and GHRH receptor analogue in post-stroke management of vasogenic edema.
Tenure: 2026-2029
Funded By: GSBTM - Title: Investigating the therapeutic relevance of IVIG for mitigating compromised immunity in offspring following stroke in pregnancy (PI, ANRF, 2026-2029)
Tenure: 2026-2029 - Title: Investigating the role of Inosine in mitigating decreased innate immune response in ischemic stroke following chronic kidney disease
Tenure: 2024-2027
Funded By: ICMR - Title: Evaluation of skeletal muscle relaxant activity and elucidate mechanism of action of a peripherally acting agent
Tenure: 2025-2027
Funded By: Industry - Title: Visualization of brain blood flow reorganization during stroke treatment in mice
Tenure: 2020-2023
Funded By: Indo-Denmark Multilateral Framework Grant - Title: To investigate intra-arterial (IA) delivery of stem cells in a rodent middle cerebral artery occlusion stroke model.
Tenure: 2020-2021
Funded By: Indo-USA Sub-Network Grant - Title: Role of Triphala and Ashwagandha in protecting mitochondrial health of neurons: A comparative evaluation of its impact on brain function and cognition.
Tenure: 2020-2023
Funded By: Industry - Title: Neuroprotective role of Phyllanthus emblica in animal model of ischemic stroke
Tenure: 2018-2021
Funded By: Industry - Title: Light amplifying carbon quantum dot embedded contact lenses for treatment of night blindness
Tenure: 2019-2022
Funded By: DBT - Title: Exploring the molecular mechanism of butter oil enriched nanoformulation in enhancing nasal to brain delivery and its potential role in promoting neurogenesis
Tenure: 2018-2020
Funded By: DST - Title: Intra-arterial delivery of brain derived neurotrophic factor (BDNF) loaded dendrimer-stabilized smart-albumin nanoparticle (DSSAN) for the treatment of ischemic stroke
Tenure: 2019-2022
Funded By: ICMR - Title: Mitochondrial protection in ischemic stroke by using microRNA mediated engineered stem cells
Tenure: 2017-2018
Funded By: ISN, USA - Title: Regulatory RNA mediated mesenchymal stem cell engineering: A safety and efficacy study in rodent model of cerebral ischemia
Tenure: 2016-2019
Funded By: DST
Patent
Patent (Filed/Granted)
Neuroprotective Phyllanthus emblica-containing compositions and methods
(International Publication Number: WO 2022/140536 A1; Date of Publication: 30/6/2022; International Application Number: PCT/US2021/064849)